Data protection Impressum

Medical Devices

Geneva-based EarlySight has raised an additional CHF 3.1 million, bringing its seed financing round to CHF 6.1 million, to launch its next-generation product and advance U.S. approval.

Retinal imaging specialist EarlySight raises CHF 3.1 million to accelerate global growth

10 September 2025

A new automated platform developed by cellvie and CSEM streamlines mitochondria isolation, advancing therapeutic transplantation for ischemia-reperfusion injury.

CSEM and cellvie automate mitochondria isolation for clinical use

9 September 2025

Bern-based medtech Rhovica Neuroimaging has secured CHF 2.3 million to accelerate development of its SoNav system for safer emergency neurosurgery.

Rhovica raises CHF 2.3 million to advance bedside neurosurgery navigation

2 September 2025

Vaud-based medtech Comphya strengthens its clinical pipeline with fresh capital and prepares for pivotal trials in the United States.

Comphya raises CHF 7.5 million for its neurostimulation therapy to treat erectile dysfunction

14 July 2025

Geneva strengthens its support for breakthrough innovation with new FIF funding awarded to InTeeth, Speqqle, and 4D-PicoSense.

Three Geneva start-ups receive support from the FONGIT Innovation Fund

9 July 2025

Western Switzerland medtech start-ups ORamaVR and Compremium are progressing toward clinical validation of their technologies, targeting major improvements in surgical training and cancer diagnostics.

ORamaVR and Compremium unveil new tools for surgical training and diagnosis

2 July 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (June 2025)

25 June 2025

Biotech KYLYS Aesthetics has raised CHF 1 million to advance clinical development of its next-generation hyaluronic acid medical devices for regenerative aesthetic medicine.

Geneva-based KYLYS raises CHF 1 million to advance regenerative aesthetic medicine

23 June 2025

Start-ups Aseptuva, Bloom Biorenewables, and Hafnova have been selected for multi-year EU-funded projects, reinforcing Western Switzerland’s importance in health tech, sustainable chemistry and cybersecurity.

Three rising Western Switzerland start-ups join major European innovation programs

3 June 2025

Geneva-based Syrhatech has raised CHF 4.5 million to expand its R&D and manufacturing of injectable hyaluronic acid-based medical devices to support growing demand in dermatology, orthopedics, and ophthalmology.

Syrhatech raises CHF 4.5 million to innovate in hyaluronic acid medical devices

27 May 2025

1 2 3 4 5 … 12